Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Swanton

Showing results (361-370 of 440) with videos related to

Pageof 44
Sort By:
Cancer Discovery|April 6, 2024
Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung CancerKatey S S Enfield, Emma Colliver, Claudia Lee, et al.
The Journal of Pathology|February 25, 2012
A whole-genome massively parallel sequencing analysis of BRCA1 mutant oestrogen receptor-negative and -positive breast cancersRachael Natrajan, Alan Mackay, Maryou B Lambros, et al.
The Journal of Infection|August 23, 2025
Third exposure to COVID-19 infection or vaccination differentially impacts T cell responsesGift Ahimbisibwe, David Greenwood, Katalin Andrea Wilkinson, et al.
Nature Communications|September 11, 2020
MCL-1 gains occur with high frequency in lung adenocarcinoma and can be targeted therapeuticallyEnkhtsetseg Munkhbaatar, Michelle Dietzen, Deepti Agrawal, et al.
Cancer Discovery|September 8, 2025
Extrachromosomal DNA-Driven Oncogene Spatial Heterogeneity and Evolution in GlioblastomaImran Noorani, Magnus Haughey, Jens Luebeck, et al.
Cancer Cell|April 17, 2018
Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung CancerMatthew D Hellmann, Tavi Nathanson, Hira Rizvi, et al.
Nature Communications|June 8, 2021
Author Correction: Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironmentMin Zhang, Jin-Li Luo, Qianqian Sun, et al.
Nature Communications|March 20, 2021
Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironmentMin Zhang, Jin-Li Luo, Qianqian Sun, et al.
The Lancet. Infectious Diseases|December 9, 2023
SARS-CoV-2 mucosal neutralising immunity after vaccinationEdward J Carr, Guilia Dowgier, David Greenwood, et al.
Nature Medicine|June 5, 2020
Publisher Correction: Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancerKroopa Joshi, Marc Robert de Massy, Mazlina Ismail, et al.
Pageof 44

Showing results (361-370 of 440) with videos related to

Sort By:
Pageof 44
Cancer Discovery|April 6, 2024
Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung CancerKatey S S Enfield, Emma Colliver, Claudia Lee, et al.
The Journal of Pathology|February 25, 2012
A whole-genome massively parallel sequencing analysis of BRCA1 mutant oestrogen receptor-negative and -positive breast cancersRachael Natrajan, Alan Mackay, Maryou B Lambros, et al.
The Journal of Infection|August 23, 2025
Third exposure to COVID-19 infection or vaccination differentially impacts T cell responsesGift Ahimbisibwe, David Greenwood, Katalin Andrea Wilkinson, et al.
Nature Communications|September 11, 2020
MCL-1 gains occur with high frequency in lung adenocarcinoma and can be targeted therapeuticallyEnkhtsetseg Munkhbaatar, Michelle Dietzen, Deepti Agrawal, et al.
Cancer Discovery|September 8, 2025
Extrachromosomal DNA-Driven Oncogene Spatial Heterogeneity and Evolution in GlioblastomaImran Noorani, Magnus Haughey, Jens Luebeck, et al.
Cancer Cell|April 17, 2018
Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung CancerMatthew D Hellmann, Tavi Nathanson, Hira Rizvi, et al.
Nature Communications|June 8, 2021
Author Correction: Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironmentMin Zhang, Jin-Li Luo, Qianqian Sun, et al.
Nature Communications|March 20, 2021
Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironmentMin Zhang, Jin-Li Luo, Qianqian Sun, et al.
The Lancet. Infectious Diseases|December 9, 2023
SARS-CoV-2 mucosal neutralising immunity after vaccinationEdward J Carr, Guilia Dowgier, David Greenwood, et al.
Nature Medicine|June 5, 2020
Publisher Correction: Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancerKroopa Joshi, Marc Robert de Massy, Mazlina Ismail, et al.
Pageof 44